1 Product identity
Ingredient risk
No flagged ingredients
Adrenosen
BrandHealth Concerns→Other Combinations Tablet or Pill 12 ingredients DSLD #72657Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2017-04-25
2 Ingredients (12)
IngredientGroupSafety
Adrenal Cortex concentrateAdrenal —
PAKPyridoxine alpha-ketoglutarate—
Proprietary BlendProprietary Blend—
PseudostellariaPseudostellaria—
DioscoreaYam (unspecified)—
DolichosDolichos (unspecified)—
OryzaRice—
Vegetable Gumvegetable gum (unspecified)—
Stearic AcidStearic Acid—
CelluloseCellulose—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Schisandra — Generally Safe
⚠ GI discomfort
⚠ May affect CYP enzymes
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
5 Data source
DSLD ID72657
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2017-04-25
6 More from Health Concerns
View Health Concerns Safety Scorecard → 25 products
AC-Q Tabs SilerCalm SpiritCir-QClear HeatColostroplexColostroplex Recovery7 Cite this page
Vancouver
Pkhakadze G. Adrenosen — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 31]. Available from: https://supplement.ge/products/adrenosen-72657/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG